Lonny Reisman, MD, CEO of HealthReveal, expects big data to help achieve the triple aim goals by combining disparate sources of rich and varied information.
Lonny Reisman, MD, CEO of HealthReveal, expects big data to help achieve the triple aim goals by combining disparate sources of rich and varied information.
Transcript (slightly modified)
How can big data help the healthcare industry achieve the triple aim goals?
I think one of the elusive goals since the first articulation of the triple aim has been actual success in any of the dimensions of it. And what big data can do, which would contribute significantly, is take advantage of all the disparate sources of very rich information that currently is just in siloes. So there might be information in the world of clinical research and evidence-based trials, there might be information sitting in delivery systems in the form of [virtual health records], there’s certainly a lot of information in pair systems (not only the cost of care but the consequences and associations of their various combinations of care), and then finally consumer sources of information.
For example, what are patients’ preferences, taking advantage of social media, and what sorts of incentives work. And right now none of that information is organized in any particular way. So to the extent that we can get over issues regarding our inoperability, make patients comfortable regarding the protection of their information as it relates to privacy, creation of standards, I think there’s a tremendous amount to be learned, and with the advent of cognitive computing capabilities, I expect to see very significant advances.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Bioinformatics, Machine Learning Reveal New Insights Into MG-Associated DCM
April 11th 2024Researchers explain that these insights have important implications, if validated in further research, as challenges with early detection of dilated cardiomyopathy complicate myasthenia gravis (MG)-prognosis.
Read More
What We’re Reading: Telehealth Debate; STD Rise Among Older Adults; PFAS Limits in Water
April 10th 2024Lawmakers are under pressure to decide the fate of COVID-era telehealth payment changes; the CDC reports an alarming increase in sexually transmitted disease (STD) cases among Americans 55 years and older; new regulations aim to reduce harmful exposure to per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals.”
Read More